home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

443.92 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

72 73 Next >

Check Out What Whales Are Doing With VRTX ↗

July 10, 2024

Via Benzinga

The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗

July 09, 2024

Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.

Via InvestorPlace

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

3 No-Brainer Stocks to Buy in July ↗

July 08, 2024

Investors shouldn't have to think too hard about these great stocks.

Via The Motley Fool

3 Pharma Stocks Already Ushering in the Next Biotech Boom ↗

July 08, 2024

So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider.

Via InvestorPlace

Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon). ↗

July 06, 2024

Vertex shares have advanced by triple digits over the past few years.

Via The Motley Fool

Why the quality investor may take a look at NASDAQ:VRTX. ↗

July 03, 2024

Examining the Quality Attributes of NASDAQ:VRTX.

Via Chartmill

$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today ↗

July 01, 2024

Via Benzinga

Peering Into Vertex Pharmaceuticals's Recent Short Interest ↗

June 26, 2024

Via Benzinga

The 3 Best Biotech Stocks to Buy in July 2024 ↗

July 05, 2024

For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024.

Via InvestorPlace

1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever ↗

July 05, 2024

It's not too late to get in on the act.

Via The Motley Fool

Did Vertex Pharmaceuticals Just Invent the Next Ozempic? ↗

July 05, 2024

Vertex Pharmaceuticals likely has a breakthrough medicine on its hands.

Via The Motley Fool

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead ↗

July 04, 2024

Eli Lilly is a good stock to buy, but these should be even better.

Via The Motley Fool

3 Top-Rated Gene Editing Stocks Actually Making Money ↗

July 03, 2024

Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.

Via InvestorPlace

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

July 02, 2024

The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.

Via MarketBeat

Topics ETFs

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis

July 02, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 Under-the-Radar Biotech Stocks With Blockbuster Potential ↗

July 02, 2024

Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three.

Via InvestorPlace

Vertex to Announce Second Quarter 2024 Financial Results on August 1

July 01, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 Breakout Biotech Stocks on Track to Double by 2032 ↗

July 01, 2024

The tech sector has been at the forefront of the market rally in 2024. Consider these breakout biotech stocks as a great way to diversify.

Via InvestorPlace

Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗

July 01, 2024

The latest bull market has plenty of intriguing buying opportunities.

Via The Motley Fool

2 Superior Growth Stocks to Buy if You Have $1,000 Right Now ↗

June 28, 2024

Growth stocks with wide moats and strong financials can compound investor returns with time.

Via The Motley Fool

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗

June 28, 2024

These healthcare stocks have clear paths to growth over the next few years.

Via The Motley Fool

2 Healthcare Stocks That Are Screaming Buys in June ↗

June 28, 2024

These top healthcare stocks are no-brainer buys in 2024 and beyond.

Via The Motley Fool

You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever. ↗

June 27, 2024

Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.

Via InvestorPlace

This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

June 27, 2024

Via Benzinga

Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued." ↗

June 27, 2024

The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.

Via The Motley Fool

3 Biotech Stocks That Could Make Your Grandchildren Rich ↗

June 27, 2024

These biotech stocks are poised to generate significant returns to investors due to their high growth potential.

Via InvestorPlace

Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy? ↗

June 25, 2024

It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes.

Via The Motley Fool

Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions

June 21, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead ↗

June 21, 2024

Lilly is a good pick...but this one is better.

Via The Motley Fool

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com